CAREDX, INC. Stock Split Ratio
CAREDX, INC. (CDNA) reported Stock Split Ratio of 14.60% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-04-21.
Discontinued › Notes › Equity
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2017-04-21
- CAREDX, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2016 was 14.60%, a 0.00% change from fiscal 2015.
- CAREDX, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2015 was 14.60%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|
| 2016-12-31 | 14.60% 10-K · filed 2017-04-21 |
| 2015-12-31 | 14.60% 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |